Virtual reality headset aims to restore lost vision
NCT ID NCT07185971
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a virtual reality headset therapy called PAVE for people with chronic vision loss from stroke, traumatic brain injury, or brain surgery. Twenty participants will use the headset three times a week for eight weeks to see if it expands their field of view. The goal is to find a safe, drug-free way to improve daily visual function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- virtual reality visual stimulation device
- What this could lead to
- If it works, this could offer a non-invasive way to partially restore vision in people with long-term visual field loss after brain injury.
- What could go wrong
- This is a very small early study with only 20 participants and no control group, so results may not be conclusive. The therapy requires frequent sessions and may not help everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOMONYMOUS HEMIANOPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. D. M. Fitzgerald & Associates
RECRUITINGCedar Rapids, Iowa, 52404, United States
-
Neuro-Vision Associates of North Texas
RECRUITINGProspect, Kentucky, 40059, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.